Evidence map›Paper›PMID 36260643›Full record

ArticlePloS one2022

A comparative analysis of current phasing and imputation software.

Adriano De Marino, Abdallah Amr Mahmoud, Madhuchanda Bose, Karatuğ Ozan Bircan, Andrew Terpolovsky, Varuna Bamunusinghe, Sandra Bohn, Umar Khan, Biljana Novković, Puya G Yazdi

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. A Benchmark of Modern Statistical Phasing Methods.bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adriano De MarinoResearch & Development, SelfDecode, Miami, FL, United States of America.ORCID 0000-0001-5487-0413
Abdallah Amr MahmoudResearch & Development, SelfDecode, Miami, FL, United States of America.ORCID 0000-0002-0311-2644
Madhuchanda BoseResearch & Development, SelfDecode, Miami, FL, United States of America.ORCID 0000-0003-0884-514X
Karatuğ Ozan BircanResearch & Development, SelfDecode, Miami, FL, United States of America.ORCID 0000-0003-0079-6144
Andrew TerpolovskyResearch & Development, SelfDecode, Miami, FL, United States of America.
Varuna BamunusingheResearch & Development, SelfDecode, Miami, FL, United States of America.
Sandra BohnResearch & Development, SelfDecode, Miami, FL, United States of America.
Umar KhanResearch & Development, SelfDecode, Miami, FL, United States of America.
Biljana NovkovićResearch & Development, SelfDecode, Miami, FL, United States of America.
Puya G YazdiResearch & Development, SelfDecode, Miami, FL, United States of America.ORCID 0000-0003-3456-8043

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-genome data has become significantly more accessible over the last two decades. This can largely be attributed to both reduced sequencing costs and imputation models which make it possible to obtain nearly whole-genome data from less expensive genotyping methods, such as microarray chips. Although there are many different approaches to imputation, the Hidden Markov Model (HMM) remains the most widely used. In this study, we compared the latest versions of the most popular HMM-based tools for phasing and imputation: Beagle5.4, Eagle2.4.1, Shapeit4, Impute5 and Minimac4. We benchmarked them on four input datasets with three levels of chip density. We assessed each imputation software on the basis of accuracy, speed and memory usage, and showed how the choice of imputation accuracy metric can result in different interpretations. The highest average concordance rate was achieved by Beagle5.4, followed by Impute5 and Minimac4, using a reference-based approach during phasing and the highest density chip. IQS and R2 metrics revealed that Impute5 and Minimac4 obtained better results for low frequency markers, while Beagle5.4 remained more accurate for common markers (MAF>5%). Computational load as measured by run time was lower for Beagle5.4 than Minimac4 and Impute5, while Minimac4 utilized the least memory of the imputation tools we compared. ShapeIT4, used the least memory of the phasing tools examined with genotype chip data, while Eagle2.4.1 used the least memory phasing WGS data. Finally, we determined the combination of phasing software, imputation software, and reference panel, best suited for different situations and analysis needs and created an automated pipeline that provides a way for users to create customized chips designed to optimize their imputation results.

Indexed as

Polymorphism, Single NucleotideSoftwareGenomeGenotypeGenotyping TechniquesOligonucleotide Array Sequence Analysis

Identifiers

PMID36260643
PMCPMC9581364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.